CARDINAL HEALTH ULTRASOUND GEL USG250BT

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2019-03-19 for CARDINAL HEALTH ULTRASOUND GEL USG250BT manufactured by Covidien.

Event Text Entries

[139421002] Had ultrasounds on (b)(6) and (b)(6) "2018", which resulted in rashes which spread over entire body - ultrasound gel product was cardinal health ultrasound gel. Have been treated with fluocinonide cream, desoximetasone cream, oral prednisone (all steroids) and tacrolimus ointment. Rash still persists and keeps spreading. Persistent painful, raw itchy rash resulted from product. Distributed by (b)(4).
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report NumberMW5085017
MDR Report Key8436315
Date Received2019-03-19
Date of Report2019-03-06
Date of Event2018-09-28
Date Added to Maude2019-03-20
Event Key0
Report Source CodeVoluntary report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationPATIENT
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCARDINAL HEALTH ULTRASOUND GEL
Generic NameMEDIA COUPLING ULTRASOUND
Product CodeMUI
Date Received2019-03-19
Catalog NumberUSG250BT
Device AvailabilityY
Device Eval'ed by MfgrI
Device Sequence No1
Device Event Key0
ManufacturerCOVIDIEN


Patients

Patient NumberTreatmentOutcomeDate
101. Deathisabilit 2019-03-19

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.